跳至主要内容
临床试验/JPRN-UMIN000003108
JPRN-UMIN000003108已完成未知

Clinical efficacy, saftey and pharmacodynamics of antifungal agents on chronic pulmonary mycosis - Clinical efficacy and of antifungal agents on pulmonary mycosis

ational Hospital Organization, Tokyo National Hospital0 个研究点目标入组 20 人开始时间: 2010年1月27日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients under treatment of radiotherapy and immunosuppressant at present 2) Patients who have serious acute diseases obviously

研究者

发起方
ational Hospital Organization, Tokyo National Hospital

相似试验

进行中(未招募)
1 期
Clinical trial to evaluate the efficacy, safety and pharmacokinetics profile of nebulized Aztreonam Lysine (AZLI) for prevention of Gram negative pneumonia in heavily colonized mechanically ventilated patientsGram negative pneumonia in heavily colonized mechanically ventilated patientsMedDRA version: 20.0Level: LLTClassification code 10035725Term: Pneumonia NOSSystem Organ Class: 100000004862
EUCTR2018-003865-32-ESAlejandro Rodriguez Oviedo - Critical Care Department – Hospital Universitario de Tarragona Joan XXIII20
尚未招募
不适用
Clofazimine and moxifloxacin PK, safety, and AccepTAbiLitY for paediatric TB treatment (CATALYST)Tuberculosis
PACTR202012756409365Stellenbosch University36
已完成
1 期
Efficacy and safety of Chinese herbal medicine (RCM-102) for treatment of seasonal allergic rhinitis (hayfever)seasonal allergic rhinitisInflammatory and Immune System - AllergiesRespiratory - Other respiratory disorders / diseasesAlternative and Complementary Medicine - Herbal remedies
ACTRN12612000209897Professor Charlie Xua104
已完成
不适用
Evaulation of the clinical efficacy and safety of the combined administration of Imidafenacin and Tamsulosin in BPH patients (in which OAB symptoms remain) who did not respond to alpha-1 blocker monotherapy.Overactive bladder
JPRN-UMIN000005012Department of Urology, University of Yamanashi, School of Medicine300
进行中(未招募)
1 期
Pharmacokinetic and pharmacodynamic evaluation of linezolid administered intravenously in MRSA-positive, morbidly obese patients with pneumonia.
EUCTR2012-005127-33-BEniversity Ghent20